430 related articles for article (PubMed ID: 28209403)
1. Small Molecules That Sabotage Bacterial Virulence.
Johnson BK; Abramovitch RB
Trends Pharmacol Sci; 2017 Apr; 38(4):339-362. PubMed ID: 28209403
[TBL] [Abstract][Full Text] [Related]
2. Antivirulence as a new antibacterial approach for chemotherapy.
Escaich S
Curr Opin Chem Biol; 2008 Aug; 12(4):400-8. PubMed ID: 18639647
[TBL] [Abstract][Full Text] [Related]
3. The biology and future prospects of antivirulence therapies.
Cegelski L; Marshall GR; Eldridge GR; Hultgren SJ
Nat Rev Microbiol; 2008 Jan; 6(1):17-27. PubMed ID: 18079741
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence.
Worthington RJ; Blackledge MS; Melander C
Future Med Chem; 2013 Jul; 5(11):1265-84. PubMed ID: 23859207
[TBL] [Abstract][Full Text] [Related]
5. Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections.
Russo TA; Spellberg B; Johnson JR
J Infect Dis; 2016 Mar; 213(6):901-3. PubMed ID: 26563238
[TBL] [Abstract][Full Text] [Related]
6. Bacterial adhesion--a source of alternate antibiotic targets.
Cusumano CK; Hultgren SJ
IDrugs; 2009 Nov; 12(11):699-705. PubMed ID: 19844856
[TBL] [Abstract][Full Text] [Related]
7. Disarming pathogens: benefits and challenges of antimicrobials that target bacterial virulence instead of growth and viability.
Totsika M
Future Med Chem; 2017 Mar; 9(3):267-269. PubMed ID: 28207349
[No Abstract] [Full Text] [Related]
8. Approaches to the Structure-Based Design of Antivirulence Drugs: Therapeutics for the Post-Antibiotic Era.
Neville N; Jia Z
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678155
[TBL] [Abstract][Full Text] [Related]
9. Novel agents to inhibit microbial virulence and pathogenicity.
Escaich S
Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
[TBL] [Abstract][Full Text] [Related]
10. Anti-virulence Strategies to Target Bacterial Infections.
Mühlen S; Dersch P
Curr Top Microbiol Immunol; 2016; 398():147-183. PubMed ID: 26942418
[TBL] [Abstract][Full Text] [Related]
11. QseC inhibitors as an antivirulence approach for Gram-negative pathogens.
Curtis MM; Russell R; Moreira CG; Adebesin AM; Wang C; Williams NS; Taussig R; Stewart D; Zimmern P; Lu B; Prasad RN; Zhu C; Rasko DA; Huntley JF; Falck JR; Sperandio V
mBio; 2014 Nov; 5(6):e02165. PubMed ID: 25389178
[TBL] [Abstract][Full Text] [Related]
12. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.
Dickey SW; Cheung GYC; Otto M
Nat Rev Drug Discov; 2017 Jul; 16(7):457-471. PubMed ID: 28337021
[TBL] [Abstract][Full Text] [Related]
13. Antivirulence compounds: a future direction to overcome antibiotic resistance?
Buroni S; Chiarelli LR
Future Microbiol; 2020 Mar; 15():299-301. PubMed ID: 32286100
[No Abstract] [Full Text] [Related]
14. Antivirulence drugs to target bacterial secretion systems.
Baron C
Curr Opin Microbiol; 2010 Feb; 13(1):100-5. PubMed ID: 20079679
[TBL] [Abstract][Full Text] [Related]
15. Targeting virulence: a new paradigm for antimicrobial therapy.
Clatworthy AE; Pierson E; Hung DT
Nat Chem Biol; 2007 Sep; 3(9):541-8. PubMed ID: 17710100
[TBL] [Abstract][Full Text] [Related]
16. Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms.
Ruer S; Pinotsis N; Steadman D; Waksman G; Remaut H
Chem Biol Drug Des; 2015 Oct; 86(4):379-99. PubMed ID: 25589217
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Screening Strategies for the Development of Anti-Virulence Inhibitors Against Staphylococcus aureus.
Cai X; Zheng W; Li Z
Curr Med Chem; 2019; 26(13):2297-2312. PubMed ID: 29165063
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in
Imdad S; Chaurasia AK; Kim KK
Front Cell Infect Microbiol; 2018; 8():152. PubMed ID: 29868508
[TBL] [Abstract][Full Text] [Related]
19. Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence Agents.
Smith RP; Paxman JJ; Scanlon MJ; Heras B
Molecules; 2016 Jul; 21(7):. PubMed ID: 27438817
[TBL] [Abstract][Full Text] [Related]
20. Bacterial virulence as a target for antimicrobial chemotherapy.
Alksne LE; Projan SJ
Curr Opin Biotechnol; 2000 Dec; 11(6):625-36. PubMed ID: 11102800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
